The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Role and Function of the 26S Proteasome in Proliferation and Apoptosis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 4×
“The parkin gene, which is implicated in the onset and progression of AR-JP (Kitada et al, 1998), encodes the 53-kd parkin protein that functions as a 972 Laboratory Investigation • August 2002 • Volume 82 • Number 8 ubiquitin-protein ligase for targeting proteins for proteasomal degradation…”
InfluentialTumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · cited 2×
“…in such case could well be mediated by a combination of up-regulation of both the genes of Bax and p21WAF1/Cip1, proapoptotic targets of p53 (El-Deiry et al, 1994; Miyashita and Reed, 1995), and by down-regulation of the antiapoptotic protein Bcl-2, which is repressed by p53 (Agarwal et al, 1998).”
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 1×
“…which is implicated in the onset and progression of AR-JP (Kitada et al, 1998), encodes the 53-kd parkin protein that functions as a 972 Laboratory Investigation • August 2002 • Volume 82 • Number 8 ubiquitin-protein ligase for targeting proteins for proteasomal degradation (Shimura et al, 2000).”
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583 · cited 1×
“In fact, this was originally demonstrated in rodent neuronal cells induced to undergo terminal neurite formation by treatment with compounds subsequently identified as specific proteasome inhibitors (Fenteany et al, 1994, 1995; Saito and Kawashima, 1989; Tsubuki et al, 1993, 1996).”
Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142 · cited 1×
“968 Laboratory Investigation • August 2002 • Volume 82 • Number 8 Cyclin D. Cyclins of the D-type represent a family of growth factor–regulated cyclins that are capable of binding CKIs such as p21Cip1/WAF1 and p27Kip1, resulting in the formation of cyclin-CKI complexes (Cheng et al, 1999).”
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848 · cited 1×
“This multimodal amplification of proteasome inhibition in the context of a pathologic amyloid metabolism is likely to explain the global impairment of proteasome activity that has been detected postmortally in cortical neurons of AD patients (Keller et al, 2000; Salon et al, 2000).”
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746 · cited 16×
“Moreover, ectopic overexpression of mutant p27Kip1, but not of wild-type p27Kip1, results in cell cycle arrest in the S-phase (Sutterluty et al, 1999), strongly suggesting that proteasomal degradation of p27Kip1 is essential for the entry into S-phase.”
InfluentialProteasomal function is impaired in substantia nigra in Parkinson’s disease
McNaught, K. S. P., & Jenner, P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01701-8 · Cited by 653
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
Luo, Y., Hurwitz, J., & Massagué, J. (1995) · Nature · doi:10.1038/375159a0 · Cited by 549 · cited 1×
“The CKI p21Cip1/WAF1 is proposed to negatively regulate G1- and early S-phase events through binding to CDKs and/or to proliferating cell nuclear antigen (PCNA) (Luo et al, 1995).”
Degradation of α-Synuclein by Proteasome
Bennett, M. C., Bishop, J. F., Leng, Y., Chock, P. B., Chase, T. N., & Mouradian, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33855 · Cited by 417
Tofaris, G. K., Layfield, R., & Spillantini, M. G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03115-5 · Cited by 363
Spinella, M. J., Freemantle, S. J., Sekula, D., Chang, J. H., Christie, A. J., & Dmitrovsky, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.22013 · Cited by 165
Cited by
Replicative senescence: a critical review
Cristofalo, V. J., Lorenzini, A., Allen, R. G., Torres, C., & Tresini, M. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.07.010 · Cited by 274
p62- and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome
Cohen-Kaplan, V., Livneh, I., Avni, N., Fabre, B., Ziv, T., Kwon, Y. T., & Ciechanover, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615455113 · Cited by 260
Naujokat, C., Berges, C., Höh, A., Wieczorek, H., Fuchs, D., Ovens, J., Miltz, M., Sadeghi, M., Opelz, G., & Daniel, V. (2007) · Immunology · doi:10.1111/j.1365-2567.2006.02487.x · Cited by 41
Self-citation
Metadata
- Authors
- Naujokat, C., & Hoffmann, S.
- Venue
- Laboratory Investigation
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 82
- Issue
- 8
- Pages
- 965-980
- ISSN
- 0023-6837 (ISSN-L)
- OpenAlex
- W2085459881
- Cited by
- 247
- References
- 15
- FWCI
- 5.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.